Cal-1 (LVsh5/C46) Drug Product
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cal-1 (LVsh5/C46) Drug Product, covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma [Phase 1, Phase 2]